Torrent Pharmaceuticals Overview

  • Year Founded
  • 1959

Year Founded

  • Status
  • Public

  • Employees
  • 17,729

Employees

  • Stock Symbol
  • TORNTPHARM

Stock Symbol

  • Investments
  • 21

  • Share Price
  • $49.33
  • (As of Thursday Closing)

Torrent Pharmaceuticals General Information

Description

Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.

Contact Information

Formerly Known As
Trinity Laboratories
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Avirat, Thaltej Shilaj Road
  • Ahmedabad, Gujarat 380059
  • India
+91 079
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
NSE
Corporate Office
  • Avirat, Thaltej Shilaj Road
  • Ahmedabad, Gujarat 380059
  • India
+91 079

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Torrent Pharmaceuticals Stock Performance

As of 19-Nov-2026, Torrent Pharmaceuticals’s stock price is $49.33. Its current market cap is $18.8B with 380M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$49.33 $49.33 $40.26 - $55.03 $18.8B 380M 318K $0.64

Torrent Pharmaceuticals Financials Summary

As of 30-Sep-2026, Torrent Pharmaceuticals has a trailing 12-month revenue of $1.85B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 21,284,821 15,258,096 12,940,193 10,983,095
Revenue 1,845,360 1,556,406 1,338,413 1,275,859
EBITDA 605,579 490,829 437,447 421,396
Net Income 229,079 244,826 226,030 200,080
Total Assets 4,644,919 4,696,422 1,752,381 1,805,966
Total Debt 1,468,696 1,592,484 374,368 482,285
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Torrent Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Torrent Pharmaceuticals‘s full profile, request access.

Request a free trial

Torrent Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system,
Pharmaceuticals
Ahmedabad, India
17,729 As of 2026

Hyderabad, India
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Torrent Pharmaceuticals Competitors (49)

One of Torrent Pharmaceuticals’s 49 competitors is Divi's Laboratories, a Corporation company based in Hyderabad, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Divi's Laboratories Corporation Hyderabad, India
Alkem Laboratories Formerly PE-Backed Mumbai, India
Ajanta Pharma Corporation Mumbai, India
Granules India Corporation Hyderabad, India
Cipla Corporation Mumbai, India
You’re viewing 5 of 49 competitors. Get the full list »

Torrent Pharmaceuticals Patents

Torrent Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025163603-A1 Direct resolution of desacetylketoconazole salt Pending 01-Feb-2024
US-20260062411-A1 Novel salt of substituted 5-fluoro-1h-pyrazolopyridines and its uses Pending 18-Aug-2022
WO-2024038398-A1 Novel salt of substituted 5-fluoro-1h-pyrazolopyridines and its uses Inactive 18-Aug-2022
WO-2023047203-A1 Combination of omzotirome and antidiabetic agent, antihypertensive agent or anti-dyslipidemic agent Inactive 25-Sep-2021
WO-2023285981-A1 Stable pharmaceutical liquid composition of nilotinib Inactive 15-Jul-2021 A61K31/506
To view Torrent Pharmaceuticals’s complete patent history, request access »

Torrent Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Torrent Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Torrent Pharmaceuticals‘s full profile, request access.

Request a free trial

Torrent Pharmaceuticals Investments & Acquisitions (21)

Torrent Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Ruby Textiles Mills (Commercial Space on the 33rd Floor in Mumbai, India) for . The deal was made on 19-Aug-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ruby Textiles Mills (Commercial Space on the 33rd Floor in Mumbai, India) 19-Aug-2026 Corporate Asset Purchase Buildings and Property
J. B. Chemicals & Pharmaceuticals 08-Jul-2026 Merger/Acquisition Pharmaceuticals
J. B. Chemicals & Pharmaceuticals 21-Jan-2026 Secondary Transaction - Private Pharmaceuticals
Boehringer Ingelheim (Three Anti-diabetes Brands in Ingelheim Am Rhein, Germany) 04-Dec-2024 Corporate Asset Purchase Buildings and Property
23IKIGAI 03-Oct-2024 Later Stage VC Drug Discovery
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Torrent Pharmaceuticals ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

25.44 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Torrent Pharmaceuticals’s complete esg history, request access »

Torrent Pharmaceuticals Exits (1)

Torrent Pharmaceuticals’s most recent exit was on 26-May-2022 from Dr Reddy's Laboratories (Styptovit-E, Finast, Finast-T and Dynapress Brands in Telangana, Hyderabad). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Dr Reddy's Laboratories (Styptovit-E, Finast, Finast-T and Dynapress Brands in Telangana, Hyderabad) 26-May-2022 Completed
To view Torrent Pharmaceuticals’s complete exits history, request access »

Torrent Pharmaceuticals Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Zyg Pharma Ahmedabad, India 1987
J. B. Chemicals & Pharmaceuticals Mumbai, India 1976
Heumann Pharma Nuremberg, Germany 1913

Torrent Pharmaceuticals FAQs

  • When was Torrent Pharmaceuticals founded?

    Torrent Pharmaceuticals was founded in 1959.

  • Where is Torrent Pharmaceuticals headquartered?

    Torrent Pharmaceuticals is headquartered in Ahmedabad, India.

  • What is the size of Torrent Pharmaceuticals?

    Torrent Pharmaceuticals has 17,729 total employees.

  • What industry is Torrent Pharmaceuticals in?

    Torrent Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Torrent Pharmaceuticals a private or public company?

    Torrent Pharmaceuticals is a Public company.

  • What is Torrent Pharmaceuticals’s stock symbol?

    The ticker symbol for Torrent Pharmaceuticals is TORNTPHARM.

  • What is the current stock price of Torrent Pharmaceuticals?

    As of 19-Nov-2026 the stock price of Torrent Pharmaceuticals is $49.33.

  • What is the current market cap of Torrent Pharmaceuticals?

    The current market capitalization of Torrent Pharmaceuticals is $18.8B.

  • What is Torrent Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for Torrent Pharmaceuticals is $1.85B.

  • Who are Torrent Pharmaceuticals’s competitors?

    Divi's Laboratories, Alkem Laboratories, Ajanta Pharma, Granules India, and Cipla are some of the 49 competitors of Torrent Pharmaceuticals.

  • What is Torrent Pharmaceuticals’s annual earnings per share (EPS)?

    Torrent Pharmaceuticals’s EPS for 12 months was $0.64.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process